News
![sarepta-logo](https://pharmaphorum.com/wp-content/uploads/2017/06/Sarepta-Logo.png)
Sarepta shares yo-yo as FDA places hold on Duchenne trial
Shares in Sarepta came under pressure after the biotech said it had temporarily halted a clinical trial of its new-generation Duchenne muscular dystrophy candidate, after a patient had a se